Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors

Abstract

A method for treating adult onset neurodegenerative diseases and diabetes by administering an effective dose of Granulocyte-Colony Stimulating Factors.

1 - 24 . (canceled) 
     
     
         25 . A method of reducing blood glucose level for at least 4 weeks in Type 2 diabetes in a human comprising:
 a. treating human stem cells in vitro with an effective dose of Granulocyte-Colony Stimulating Factor; and   b. injecting an effective amount of said treated human stem cells into a human.   
     
     
         26 . The method of  claim 25 , monitoring blood glucose level and repeating a course of a Granulocyte-Colony Stimulating Factor every 2 to 18 weeks when blood glucose level is elevated over normal blood glucose level. 
     
     
         27 . The method of  claim 25 , wherein said human stem cells are selected from a group consisting of harvested umbilical stem cells, adult stem cells, progenitor stem cells, or stem cell lines. 
     
     
         28 . The method of  claim 25 , further comprising administering said human with an effective dose of second compound or molecule that enhances or elevates a population of progenitor cells or stem cells. 
     
     
         29 . The method of  claim 28  wherein is said second compound is AMD100 or identical compound. 
     
     
         30 . A method of reducing blood glucose level for at least 4 weeks in Type 2 diabetes in a human comprising:
 a. injecting an effective amount of said human stem cells into a human; and   b. administering course of an effective dose of a Granulocyte-Colony Stimulating Factor.   
     
     
         31 . The method of  claim 30 , further comprising monitoring blood glucose level after the administration of an effective dose of Granulocyte-Colony Stimulating Factor and repeating a course of a Granulocyte-Colony Stimulating Factor every 2 to 18 weeks when blood glucose level is elevated over normal blood glucose level. 
     
     
         32 . The method of  claim 30 , further comprising administering said human with an effective dose of second compound or molecule that enhances or elevates a population of progenitor cells or stem cells. 
     
     
         33 . The method of  claim 30 , wherein said human stem cells are harvested from a human after the administration of an effective dose of Granulocyte-Colony Stimulating Factor. 
     
     
         34 . The method of  claim 33 , wherein said harvested human stem cells are selected from a group consisting of adult stem cells, progenitor stem cells, or stem cell lines. 
     
     
         35 . The method of  claim 34 , wherein is said second compound is AMD100 or identical compound.